Evidence map›Paper›PMID 36992690›Full record

ArticleFrontiers in cellular and infection microbiology2023

Combination of

Wei Lv, Di Zhang, Tian He, Yingying Liu, Limei Shao, Zhongping Lv, Xiaoping Pu, Yufang Wang, Ling Liu

Open access · goldFull text read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Synthetic and systems biotechnology · 2027
    Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Anti-Obesity Effect of Kimchi with Starter Cultures in 3T3-L1 Cells.Journal of microbiology and biotechnology · 2024
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Wei LvDepartment of Gastroenterology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Di ZhangDepartment of Urology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
Tian HeDepartment of Gastroenterology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Yingying LiuDepartment of Gastroenterology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Limei ShaoDepartment of Gastroenterology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Zhongping LvTechnology Research Institute of Shuxi Condiments of Sichuan Cuisine Co. LTD, Chengdu, Sichuan, China.
Xiaoping PuTechnology Research Institute of Shuxi Condiments of Sichuan Cuisine Co. LTD, Chengdu, Sichuan, China.
Yufang WangDepartment of Gastroenterology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Ling LiuDepartment of Gastroenterology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
West China Hospital of Sichuan University · CNCapital Medical University · CNSichuan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The gut microbiome has been considered to play an important role in inflammatory bowel disease (IBD). Our previous study reported that tacrolimus-altered gut microbiota elicited immunoregulatory effects in both colonic mucosa and circulation, contributing to an increased allograft survival rate in mice. Here, we aimed to observe the changes in the tacrolimus-induced microbiome in a dextran sulfate sodium (DSS)-induced colitis mouse model and explore the possibility and efficacy of combination therapy with tacrolimus and the microbiome on colitis. Mice were divided into the control, DSS, tacrolimus monotherapy and tacrolimus plus

Indexed as

ColitisLactiplantibacillus plantarumAnimalsColonDextran SulfateDisease Models, AnimalInflammationLactobacillusMiceMice, Inbred C57BLRNA, Ribosomal, 16STacrolimusTandem Mass SpectrometryDextran SulfateRNA, Ribosomal, 16STacrolimusbile acidcolitisgut microbiomeLactobacillus plantarumtacrolimus

Identifiers

PMID36992690
PMCPMC10040537
OpenAlexW4324085418

What OpenQuestion holds

Textfull text, public
LicenceCC BY
reference markers read1
measurements read67
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.